- Home
- CUE vs CURV Comparison
CUE vs CURV Comparison
Compare CUE & CURV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CUE | CURV |
|---|---|---|
| Founded | 2014 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Clothing/Shoe/Accessory Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 233.5M | 219.9M |
| IPO Year | 2017 | 2021 |
Fundamental Metrics
Financial Performance| Metric | CUE | CURV |
|---|---|---|
| Price | $28.95 | $2.28 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 6 |
| Target Price | ★ $120.00 | $1.59 |
| AVG Volume (30 Days) | ★ 202.0K | 201.7K |
| Earning Date | 05-13-2026 | 06-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 61.11 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $27,466,000.00 | ★ $1,000,092,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.15 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 195.75 | N/A |
| 52 Week Low | $0.17 | $0.94 |
| 52 Week High | $45.50 | $2.86 |
Technical Indicators
Market Signals| Indicator | CUE | CURV |
|---|---|---|
| Relative Strength Index (RSI) | 52.45 | 52.16 |
| Support Level | $24.70 | $1.01 |
| Resistance Level | $33.95 | $2.32 |
| Average True Range (ATR) | 3.76 | 0.13 |
| MACD | 0.19 | -0.01 |
| Stochastic Oscillator | 53.77 | 56.36 |
Price Performance
Historical ComparisonAbout CUE Cue Biopharma Inc.
Cue Biopharma Inc is a clinical-stage therapeutics company focused on advancing a robust portfolio of potentially transformative therapies aimed at enabling functional cures across immunological disorders. Its product pipeline includes CUE-221, an anti-IgE antibody candidate being developed for allergic diseases. The company has also developed the Immuno-STAT platform for targeting disease-related T cells and is developing CUE-401, an IL-2 and TGF-B therapeutic candidate for autoimmune diseases.
About CURV Torrid Holdings Inc.
Torrid Holdings Inc is a direct-to-consumer brand in North America dedicated to offering a diverse assortment of stylish apparel, intimates, and accessories skillfully designed for curvy women. Its extensive collection features high-quality merchandise, including tops, bottoms, denim, dresses, intimates, activewear, footwear, and accessories. The company has one reportable segment, which includes the operation of its e-Commerce platform and stores.